Both compounds interact with fundamental healing processes, but through different pathways that create additive or synergistic effects when combined
Retatrutide is an investigational peptide compound that acts as a triple agonist, targeting three hormone receptors simultaneously: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
Peptides that more directly influence testosterone include hCG, which stimulates testicular production, and kisspeptin-10, which activates the hypothalamic signaling that drives testosterone release
Therapies like BPC-157 may one day become supportive tools in this toolkit, but they must be considered experimental
More than half (52%) of those did not tell their doctor, researchers at the University of Manchester reported in the British Journal of General Practice